Marvin-Peek, J., DiNardo, C. D. (2026). Reply to: Late Nonrelapse Mortality: A Hidden Risk in Triplet Therapy for IDH -Mutated AML?. Journal of Clinical Oncology. https://doi.org/10.1200/jco-25-02252